Paying users zone. Data is covered by hidden.

  • Get to Allergan PLC for $15.99, or

  • get to whole website for at least 3 months from $49.99.

Microsoft Excel LibreOffice Calc


Statement of Financial Position, Assets

Difficulty: Beginner

The statement of financial position provides creditors, investors, and analysts with information on company's resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company's assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Allergan PLC, Consolidated Statement of Financial Position, Assets

USD $ in thousands

Microsoft Excel LibreOffice Calc
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Cash and cash equivalents hidden hidden hidden hidden hidden
Short-term investments hidden hidden hidden hidden hidden
Teva shares hidden hidden hidden hidden hidden
Marketable securities hidden hidden hidden hidden hidden
Accounts receivable, net hidden hidden hidden hidden hidden
Inventories hidden hidden hidden hidden hidden
Prepaid taxes hidden hidden hidden hidden hidden
Prepaid insurance hidden hidden hidden hidden hidden
Royalty receivables hidden hidden hidden hidden hidden
Sales and marketing hidden hidden hidden hidden hidden
Other hidden hidden hidden hidden hidden
Prepaid expenses and other current assets hidden hidden hidden hidden hidden
Current assets held for sale hidden hidden hidden hidden hidden
Deferred tax assets hidden hidden hidden hidden hidden
Current assets hidden hidden hidden hidden hidden
Property, plant and equipment, net hidden hidden hidden hidden hidden
Legacy Allergan Deferred executive compensation investments hidden hidden hidden hidden hidden
Equity method investments hidden hidden hidden hidden hidden
Cost method investments hidden hidden hidden hidden hidden
Other long-term investments hidden hidden hidden hidden hidden
Taxes receivable hidden hidden hidden hidden hidden
Other assets hidden hidden hidden hidden hidden
Investments and other assets hidden hidden hidden hidden hidden
Non current assets held for sale hidden hidden hidden hidden hidden
Deferred tax assets hidden hidden hidden hidden hidden
Product rights and other intangibles hidden hidden hidden hidden hidden
Goodwill hidden hidden hidden hidden hidden
Non current assets hidden hidden hidden hidden hidden
Total assets hidden hidden hidden hidden hidden
Source: Allergan PLC, Annual Reports
Item Description The company
Cash and cash equivalents Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents. Allergan PLC's cash and cash equivalents increased from 2015 to 2016 and from 2016 to 2017.
Marketable securities Total debt and equity financial instruments including: (1) securities held-to-maturity, (2) trading securities, and (3) securities available-for-sale which are intended to be held for less than one year or the normal operating cycle, whichever is longer. Allergan PLC's marketable securities increased from 2015 to 2016 but then slightly declined from 2016 to 2017 not reaching 2015 level.
Accounts receivable, net Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Allergan PLC's accounts receivable, net increased from 2015 to 2016 and from 2016 to 2017.
Inventories Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer). Allergan PLC's inventories declined from 2015 to 2016 but then increased from 2016 to 2017 not reaching 2015 level.
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Allergan PLC's current assets increased from 2015 to 2016 but then slightly declined from 2016 to 2017 not reaching 2015 level.
Property, plant and equipment, net Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, and production equipment. Allergan PLC's property, plant and equipment, net increased from 2015 to 2016 and from 2016 to 2017.
Non current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Allergan PLC's non current assets declined from 2015 to 2016 and from 2016 to 2017.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Allergan PLC's total assets declined from 2015 to 2016 and from 2016 to 2017.